Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07093918 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Artificial Intelligence for Reconstruction of Echocardiography Studies

Study acronym: AIRES
StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Jan 2026 to Apr 2026
    • Primary completion date: Jan 2028 to Apr 2028
    • Study completion date: Jul 2030 to Nov 2030
    v4
  2. Primary completion date: Dec 2027 to Jan 2028
    • Study completion date: Jun 2029 to Jul 2030
    • Start date: Dec 2025 to Jan 2026
    v3
  3. Primary completion date: Nov 2027 to Dec 2027
    • Study completion date: May 2029 to Jun 2029
    • Start date: Nov 2025 to Dec 2025
    • Study description expanded, about 33 words
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To investigate the clinical utility of both 3D and 2D artificial intelligence reconstruction echocardiography (V-echo and L-echo) assessment against conventional echocardiography and clinical cardiovascular magnetic resonance (CMR) imaging for the characterisation of cardiac function and detection of cardiotoxicity in patients receiving chemotherapy. Diagnostic accuracy of V-echo and L-echo for quantification of cardiac chamber sizes and systolic function (left ventricular ejection fraction (LVEF) and strain analyses) versus conventional echocardiography (C-echo) and CMR; workflow measures including imaging temporal measures of image acquisition, registration and analysis versus conventional approaches; survey of markers of acceptability by patients and sonographers; cost effectiveness analysis of V-echo and L-echo versus conventional echocardiography; assessment of the relationship between 3D strain parameters derived from V-echo data, 2D strain parameters derived from L-echo and correlation with conventional markers of cardiac function, namely LVEF and global longitudinal strain.
Trial Details
NCT Number NCT07093918
Lead Sponsor The Royal Wolverhampton Hospitals NHS Trust
Collaborators: VentriPoint Diagnostics Ltd.
Conditions
(from sponsor)		 Cardiotoxicity
Related terms Cardiotoxicity
Enrollment 120 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov